Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Deep Brain Stimulation Systems Healthcare professionals

Talk to a Medtronic rep

Speak to your local Medtronic representative to learn more about DBS.

Percept™ PC DBS system

Closeup of the Percept PC neurostimulator for deep brain stimulation.

The first complete recharge-free DBS system with sensing, directionality*, and visual programming giving you access to data-driven insights you need to make informed decisions.

Indications, Safety, and Warnings

Product Details

Percept™RC DBS system 

Percept™ RC Neurostimulation System
The first complete rechargeable DBS system with sensing, directionality, and visual programming giving you access to data-driven insights you need to make informed decisions. Product Details

SenSight™ directional leads

Sensight

The first-of-its-kind sensing-enabled directional leads with benefits of directionality plus the power of sensing.

Indications, Safety, and Warnings

Product Details

Adaptive BrainSense™ technology

aDBS devices loop with on brand pink and blue colours
The Percept™ family with adaptive BrainSense™ technology automatically adjusts therapeutic stimulation to maximize motor symptom (rigidity, bradykinesia, tremor) control throughout the day and night. Product Details

SureTune™ 4 Software

Screen shot of the Activa Clinician Programmer shown on an iPad
SureTune™ 4 software patient-specific anatomy, lead location and orientation can be pulled into the DBS Clinician Programmer. For a visually informed programming session, streamline your directional lead programming workflow. Product Details
*

Medtronic’s Activa™ PC+S device received CE Mark on January 17, 2013, but was not commercially distributed.

Brief Statement:

This material should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s) manuals.medtronic.com.

Please note that the intended use of a product may vary depending on geographical approvals.

See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.

For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing an MRI.

If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com.

Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser. Medtronic products placed on European markets bear the CE mark and the UKCA mark (if applicable).

For any further information, contact your local Medtronic representative and/or consult Medtronic’s websites.

† The sensing feature of the Percept™ PC and Percept™ RC systems is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status. The majority of patients with Parkinson’s disease have an identifiable signal.2 Signal may not be present or measurable in patients treated for essential tremor, dystonia or epilepsy.

References

1

Darcy N, Lofredi R, Al-Fatly B, et al. Spectral and spatial distribution of subthalamic beta peak activity in Parkinson's disease patients. Exp Neurol. 2022;356:114150. doi:10.1016/j.expneurol.2022.114150

2

Thenaisie Y, Palmisano C, Canessa A, et al. Towards adaptive deep brain stimulation: clinical and technical notes on a novel commercial device for chronic brain sensing. J Neural Eng. 2021;18(4):10.1088/1741-2552/ac1d5b. Published 2021 Aug 31. doi:10.1088/1741-2552/ac1d5b